SGK1 was reported to be up-regulated in both AML, CML, and B-cell lymphoma, and has been shown to play a role in both chemotherapy resistance and radio-resistance due to its structural similarities to AKT24,25. The gene discussed is SGK1; the disease is B-cell non-Hodgkin lymphoma.